[go: up one dir, main page]

IL138732A0 - The use of polyamines in the treatment of dermatological symptoms - Google Patents

The use of polyamines in the treatment of dermatological symptoms

Info

Publication number
IL138732A0
IL138732A0 IL13873299A IL13873299A IL138732A0 IL 138732 A0 IL138732 A0 IL 138732A0 IL 13873299 A IL13873299 A IL 13873299A IL 13873299 A IL13873299 A IL 13873299A IL 138732 A0 IL138732 A0 IL 138732A0
Authority
IL
Israel
Prior art keywords
polyamines
treatment
dermatological symptoms
dermatological
symptoms
Prior art date
Application number
IL13873299A
Original Assignee
Univ Manitoba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manitoba filed Critical Univ Manitoba
Publication of IL138732A0 publication Critical patent/IL138732A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13873299A 1998-04-03 1999-04-06 The use of polyamines in the treatment of dermatological symptoms IL138732A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2234196 1998-04-03
PCT/CA1999/000285 WO1999051213A2 (en) 1998-04-03 1999-04-06 The use of polyamines in the treatment of dermatological symptoms

Publications (1)

Publication Number Publication Date
IL138732A0 true IL138732A0 (en) 2001-10-31

Family

ID=4162303

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13873299A IL138732A0 (en) 1998-04-03 1999-04-06 The use of polyamines in the treatment of dermatological symptoms

Country Status (6)

Country Link
EP (1) EP1075254A2 (en)
JP (1) JP2002510618A (en)
AU (1) AU3133399A (en)
IL (1) IL138732A0 (en)
MX (1) MXPA00009705A (en)
WO (1) WO1999051213A2 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003013245A1 (en) 2001-08-07 2003-02-20 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
DE10219644A1 (en) * 2002-05-02 2003-11-20 Johannes Wohlrab Use of agmatine for topical application
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
US7456222B2 (en) 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US7652039B2 (en) 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
WO2004073701A1 (en) * 2003-02-19 2004-09-02 Kuniyasu Soda Lfa-1 inhibitors and use thereof
ITMI20031570A1 (en) * 2003-07-31 2005-02-01 Giuliani Spa COMPOSITION FOR DIETARY, PHARMACEUTICAL OR COSMETIC USE
EP1670314A4 (en) 2003-09-05 2009-02-25 Sequella Inc Methods and compositions comprising diamines as new anti-tubercular therapeutics
CA2567311A1 (en) * 2004-06-14 2005-12-22 Unilever Plc Method of decreasing sebum production and pore size
US8221046B2 (en) 2005-02-25 2012-07-17 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof
US8278359B2 (en) * 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US20060193814A1 (en) 2005-02-25 2006-08-31 Eduardo Ruvolo Compositions for the treatment of signs of aging
JP2008156330A (en) * 2006-04-26 2008-07-10 Toyobo Co Ltd Activating agent and anti-aging agent
WO2008051080A1 (en) * 2006-10-25 2008-05-02 Fridtjof Bjerke Skin cream comprising a combination of aloe vera and spermine
WO2008113364A2 (en) * 2007-03-20 2008-09-25 Recepticon Aps Amino derivatives to prevent nephrotoxicity and cancer
WO2009067799A1 (en) * 2007-11-27 2009-06-04 The University Of Manitoba Use of transglutaminase inhibitor in skin treatment
SMT201800694T1 (en) * 2010-08-04 2019-01-11 Pierrel Pharma S R L COMPOSITIONS COMPRISING SUPRAMOLECULAR COMPLEXES OF POLYANIONIC POLYMERS AND SPERMIDINE FOR USE IN THE TREATMENT OF PERIODONTIUM AND DAMAGED ORAL TISSUE
CA2807266C (en) * 2010-08-04 2020-03-24 Tixupharma Supramolecular complexes of polyanionic polymers and spermidine in tissue maintenance and repair
KR101420267B1 (en) 2011-10-10 2014-07-17 대구대학교 산학협력단 Pharmaceutical composition for preventing and treating inflammation comprising polyamine as effective component
ITMI20120363A1 (en) * 2012-03-08 2013-09-09 Carlo Angelo Ghisalberti COMPOSITIONS FOR THE TREATMENT OF VULVODINIA
WO2018059214A1 (en) 2016-09-29 2018-04-05 广州君赫生物科技有限公司 Compounds affecting saicar synthesis, and applications
WO2018090149A1 (en) * 2016-11-21 2018-05-24 Vivier Canada Inc. Putrescine slow-release topical formulations
WO2018126321A1 (en) * 2017-01-06 2018-07-12 Vivier Canada Inc. Putrescine topical barrier formulation
NZ757708A (en) 2017-04-20 2022-01-28 Geneheal Biotechnology Co Ltd Applications of spermine and its derivative in preparation of antitumor drug
AU2018253689B2 (en) 2017-04-20 2020-07-23 Geneheal Biotechnology Co., Ltd. Applications of spermidine and its derivative
CN111479798B (en) 2018-05-04 2024-11-01 奥法兰股份公司 Crystal form of triethylenetetramine tetrahydrochloride and its medical use
US20210212964A1 (en) * 2018-06-08 2021-07-15 Vivier Canada Inc. Sterile topical saline putrescine formulation and uses thereof
JP7411983B2 (en) * 2019-08-27 2024-01-12 国立研究開発法人物質・材料研究機構 Anti-inflammatory agents, prefilled syringes, and kits
JP7600521B2 (en) * 2019-11-12 2024-12-17 東洋紡株式会社 Anti-inflammatory agents
US20250228796A1 (en) * 2022-03-22 2025-07-17 Sato Pharmaceutical Co., Ltd. Skeletal muscle enhancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061775A (en) * 1975-09-02 1977-12-06 Merck & Co., Inc. Polyamine compounds as antibacterial agents
US4112067A (en) * 1977-02-17 1978-09-05 The Dow Chemical Company Method for treating poison ivy dermatitis using certain polyamines and polytertiaryamides
US4507321A (en) * 1982-02-17 1985-03-26 The Research Foundation Of State University Of New York Epithelial cell growth regulating composition containing polyamines and a method of using same
DE69018099T2 (en) * 1989-01-10 1995-08-03 Merrell Dow Pharma Polyamine derivatives as antineoplastic agents.
ES2177527T3 (en) * 1992-03-23 2002-12-16 Univ Manitoba USE OF A TRANSGLUTAMINASE INHIBITOR FOR THE TREATMENT OF CICATRIAL FABRICS.
MX9705954A (en) * 1995-02-03 1998-02-28 Cosmederm Technologies Formulations and methods for reducing skin irritation.
EP0884046A1 (en) * 1997-05-30 1998-12-16 Sara Lee/DE N.V. Cosmetic composition with photoprotective properties

Also Published As

Publication number Publication date
JP2002510618A (en) 2002-04-09
MXPA00009705A (en) 2003-07-14
EP1075254A2 (en) 2001-02-14
AU3133399A (en) 1999-10-25
WO1999051213A3 (en) 1999-12-23
WO1999051213A2 (en) 1999-10-14

Similar Documents

Publication Publication Date Title
IL138732A0 (en) The use of polyamines in the treatment of dermatological symptoms
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
GB0106183D0 (en) Improvements in or relating to the treatment of lesions
GB0109414D0 (en) Well treatment fluids and methods for the use thereof
ID28981A (en) HEKSANA 3-AZABISIKLO (3.1.0) USES IN THERAPY
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU2002243363A1 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
HUP0203811A3 (en) Use of polymeric material in the treatment of hard surfaces
GB9912159D0 (en) Improvements in and relating to the treatment of water
AU2001253886A1 (en) Methylxanthines in the diagnosis and treatment of autistic disorder
GB9808420D0 (en) Improvements in or relating to cosmetic treatments
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
AU6091299A (en) Treatment device, treatment bed to be used therein and the use thereof
IS5324A (en) (S) 2-Methylamino-2-phenyl-n-butyl 3,4,5-trimethoxy-benzoate, its use in the treatment of chronic pain
MXPA02012942A (en) New bispidine compounds and their use in the treatment of cardiac arrhythmias.
EP1032266A4 (en) Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis
GB9810920D0 (en) Therapeutic use
GB9812662D0 (en) Therapeutic use
GB9816897D0 (en) Therapeutic use
ID28817A (en) USE OF TETRAHIDROPIRIDIN (OR 4-HIDROPIPERIDIN) -BUTILAZOL DRUGS IN THE MAKING OF DRUGS FOR PAIN TREATMENT
GB9821179D0 (en) Therapeutic use
GB9811624D0 (en) Therapeutic use
GB2333045B (en) Swab for use in acupuncture
SI1011649T1 (en) Use of endipalene in the treatment of psoriasis
IL127040A0 (en) Use of substituted azaspirane in the treatment of asthma